- Home
- FND vs ROIV Comparison
FND vs ROIV Comparison
Compare FND & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | ROIV |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 14.1B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FND | ROIV |
|---|---|---|
| Price | $62.05 | $21.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $82.71 | $21.94 |
| AVG Volume (30 Days) | 2.3M | ★ 6.7M |
| Earning Date | 10-30-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.08 | N/A |
| EPS | ★ 2.00 | N/A |
| Revenue | ★ $4,661,833,000.00 | $20,329,000.00 |
| Revenue This Year | $6.24 | N/A |
| Revenue Next Year | $7.92 | $376.94 |
| P/E Ratio | $30.58 | ★ N/A |
| Revenue Growth | ★ 6.04 | N/A |
| 52 Week Low | $55.11 | $8.73 |
| 52 Week High | $113.26 | $22.45 |
Technical Indicators
Market Signals| Indicator | FND | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 62.44 |
| Support Level | $60.72 | $20.14 |
| Resistance Level | $65.30 | $21.48 |
| Average True Range (ATR) | 2.49 | 0.71 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 24.72 | 65.96 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.